American consulting firm in nonclinical safety and toxicology which supports pharmaceutical and biotechnology companies through drug development. Plans and oversees nonclinical safety programmes, designs and monitors toxicology, safety pharmacology and genetic toxicology studies at contract laboratories, interprets the data and writes and reviews the nonclinical sections of regulatory submissions for investigational new drug applications and marketing dossiers.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen